Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Bcl-2 antisense therapy in hematologic malignancies
Asher Chanan-Khan
Hematology / Oncology / Cancer Center / Breast Clinic
Research output
:
Contribution to journal
›
Review article
›
peer-review
17
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Bcl-2 antisense therapy in hematologic malignancies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
oblimersen
100%
Hematologic Neoplasms
69%
B-Cell Chronic Lymphocytic Leukemia
48%
Oncogene Proteins
38%
Non-Hodgkin's Lymphoma
21%
Down-Regulation
16%
Clinical Trials
14%
Drug Therapy
13%
Multiple Myeloma
11%
Therapeutics
11%
Acute Myeloid Leukemia
10%
Survival
6%
Neoplasms
3%